Elicio Therapeutics, Inc. (ELTX) Net margin 2020–2022
Elicio Therapeutics, Inc. (ELTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1225.9%FY2022 · since FY2020: -2781.5% → -1225.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -1225.9% | -1033.1 pp |
| FY2021 | -192.8% | +2588.7 pp |
| FY2020 | -2781.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice